APA

Langefeld C. D., Divers J., Pajewski N. M., Hawfield A. T., Reboussin D. M., Bild D. E., Kaysen G. A., Kimmel P. L., Raj D. S., Ricardo A. C., Wright J. T., Sedor J. R., Rocco M. V. & Freedman B. I. (20160229). Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. : Kidney international.

Chicago

Langefeld Carl D, Divers Jasmin, Pajewski Nicholas M, Hawfield Amret T, Reboussin David M, Bild Diane E, Kaysen George A, Kimmel Paul L, Raj Dominic S, Ricardo Ana C, Wright Jackson T, Sedor John R, Rocco Michael V and Freedman Barry I. 20160229. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. : Kidney international.

Harvard

Langefeld C. D., Divers J., Pajewski N. M., Hawfield A. T., Reboussin D. M., Bild D. E., Kaysen G. A., Kimmel P. L., Raj D. S., Ricardo A. C., Wright J. T., Sedor J. R., Rocco M. V. and Freedman B. I. (20160229). Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. : Kidney international.

MLA

Langefeld Carl D, Divers Jasmin, Pajewski Nicholas M, Hawfield Amret T, Reboussin David M, Bild Diane E, Kaysen George A, Kimmel Paul L, Raj Dominic S, Ricardo Ana C, Wright Jackson T, Sedor John R, Rocco Michael V and Freedman Barry I. Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial. : Kidney international. 20160229.